Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · SBB

System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

The colorectal neoplasia RNA and hemoglobin assay is a non-invasive, qualitative in vitro diagnostic intended for the detection of colorectal neoplasia associated RNA markers and for the presence of occult hemoglobin in human stool. The test is to aid in the detection of colorectal cancer (CRC) and advanced adenomas (AA). The test is not a replacement for diagnostic colonoscopy. It is indicated for use in adults 45 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening. A positive result may indicate the presence of CRC or AA and should be followed by a diagnostic colonoscopy.

Product / regulatory recordCompanyPathwayDecision dateSource
ColoSenseP230001/S014
Geneoscopy, Inc.PMA supplementSep 8, 2026FDA
ColoSenseP230001/S012
Geneoscopy, Inc.PMA supplementAug 27, 2026FDA
ColoSenseP230001/S011
Geneoscopy, Inc.PMA supplementOct 24, 2025FDA
ColoSenseP230001/S009
Geneoscopy, Inc.PMA supplementSep 15, 2025FDA
ColoSenseP230001/S010
Geneoscopy, Inc.PMA supplementAug 14, 2025FDA
ColoSenseP230001
Geneoscopy, Inc.PMA approvalMay 3, 2024FDA
Source information

Follow the FDA links to view the original records.

All device categories